Back to Search
LESLIE LOTHSTEIN, PH.D.
PH.D.
Clinical Psychologist
NPI: 1790898559Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
1295(CT)
Research & Publications (14)
Treatment of non-incarcerated sexually compulsive/addictive offenders in an integrated, multimodal, and psychodynamic group therapy model.
PMID 11582900·Int J Group Psychother·2001
8-other
N-Benzyladriamycin-14-valerate (AD 198): a non-cardiotoxic anthracycline that is cardioprotective through PKC-epsilon activation.
PMID 17693586·J Pharmacol Exp Ther·2007
7-preclinical
Phosphorylation of mitochondrial phospholipid scramblase 3 by protein kinase C-delta induces its activation and facilitates mitochondrial targeting of tBid.
PMID 17226776·J Cell Biochem·2007
8-other
N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity.
PMID 17187856·Leuk Res·2007
8-other
N-benzyladriamycin-14-valerate (AD 198) activates protein kinase C-delta holoenzyme to trigger mitochondrial depolarization and cytochrome c release independently of permeability transition pore opening and Ca2+ influx.
PMID 16702805·Anticancer Drugs·2006
7-preclinical
N-benzyladriamycin-14-valerate (AD198) induces apoptosis through protein kinase C-delta-induced phosphorylation of phospholipid scramblase 3.
PMID 16267027·Cancer Res·2005
8-other
Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines.
PMID 15044634·Mol Pharmacol·2004
7-preclinical
ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage.
PMID 14966265·Mol Cell Biol·2004
7-preclinical
Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity.
PMID 12479266·Mol Cancer Ther·2002
7-preclinical
Novel extranuclear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis.
PMID 12479265·Mol Cancer Ther·2002
7-preclinical
Anthracycline drug targeting: cytoplasmic versus nuclear--a fork in the road.
PMID 11768330·Drug Resist Updat·2001
4-observational
Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta.
PMID 11297449·J Med Chem·2001
8-other
Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288).
PMID 11077044·Biochem Pharmacol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 RETREAT AVE
HARTFORD, CT 06106 - Phone
- (860) 545-0716
Quick Facts
- NPI
- 1790898559
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile